X D Ji - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

X D Ji

Showing results (21-30 of 54) with videos related to

Pageof 6

Sort By:

European Journal of Pharmacology|February 21, 1994

Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in miceD K Von Lubitz, I A Paul, X D Ji, et al.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica|December 1, 1980

[GC/MS analysis of the essential oil of Backea frutrescens Linn (author's transl)]X D Ji, G L Zhao, Q L Pu, et al.

Journal of Medicinal Chemistry|November 8, 1996

6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonistsJ L Jiang, A M van Rhee, N Melman, et al.

Bioconjugate Chemistry|March 1, 1991

Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptorsD L Boring, X D Ji, J Zimmet, et al.

Journal of Medicinal Chemistry|November 11, 1994

Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivativesH O Kim, X D Ji, N Melman, et al.

Journal of Medicinal Chemistry|September 30, 1994

Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptorsH O Kim, X D Ji, N Melman, et al.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 20, 2021

Over-activation of EFTUD2 correlates with tumor propagation and poor survival outcomes in hepatocellular carcinomaC Lv, X J Li, L X Hao, et al.

Journal of Medicinal Chemistry|October 14, 1994

2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptorsH O Kim, X D Ji, S M Siddiqi, et al.

European Journal of Pharmacology|April 21, 1994

Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemiaD K Von Lubitz, R C Lin, N Melman, et al.

Journal of Pharmaceutical Sciences|January 1, 1994

Adenosine receptor prodrugs: synthesis and biological activity of derivatives of potent, A1-selective agonistsM C Maillard, O Nikodijević, K F LaNoue, et al.

Pageof 6

Search research articles

Showing results (21-30 of 54) with videos related to

Sort By:

Pageof 6

European Journal of Pharmacology|February 21, 1994

Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in miceD K Von Lubitz, I A Paul, X D Ji, et al.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica|December 1, 1980

[GC/MS analysis of the essential oil of Backea frutrescens Linn (author's transl)]X D Ji, G L Zhao, Q L Pu, et al.

Journal of Medicinal Chemistry|November 8, 1996

6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonistsJ L Jiang, A M van Rhee, N Melman, et al.

Bioconjugate Chemistry|March 1, 1991

Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptorsD L Boring, X D Ji, J Zimmet, et al.

Journal of Medicinal Chemistry|November 11, 1994

Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivativesH O Kim, X D Ji, N Melman, et al.

Journal of Medicinal Chemistry|September 30, 1994

Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptorsH O Kim, X D Ji, N Melman, et al.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 20, 2021

Over-activation of EFTUD2 correlates with tumor propagation and poor survival outcomes in hepatocellular carcinomaC Lv, X J Li, L X Hao, et al.

Journal of Medicinal Chemistry|October 14, 1994

2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptorsH O Kim, X D Ji, S M Siddiqi, et al.

European Journal of Pharmacology|April 21, 1994

Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemiaD K Von Lubitz, R C Lin, N Melman, et al.

Journal of Pharmaceutical Sciences|January 1, 1994

Adenosine receptor prodrugs: synthesis and biological activity of derivatives of potent, A1-selective agonistsM C Maillard, O Nikodijević, K F LaNoue, et al.

Pageof 6